Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000220291 represents a **pseudogene**, which means it is a genomic region highly similar in sequence to the Hormonally upregulated Neu-associated kinase (HUNK) gene but is nonfunctional; it does not produce a functional protein product and has no known biological activity, therapeutic relevance, or drug interactions[2][3][1]. Pseudogenes accumulate sequence changes over time and are not under selective pressure, making them generally irrelevant for targeted therapy or biomarker use[3]. This entry should not be treated as a valid therapeutic target, receptor, enzyme, or functional protein. If you want information about the actual, functional HUNK protein, refer to Hormonally up-regulated Neu tumor-associated kinase (abbreviation: HUNK)[4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of hormonally upregulated Neu-associated kinase HUNK.